The answer so far

Small human reports have compared Selank with anxiety medicines or studied it alongside one. Their available abstracts report encouraging effects, but leave important questions about the comparisons, safety and long-term outcomes unanswered. They do not establish that Selank is equivalent to a prescribed medicine or that combining them is safe.123

On this page
  1. Why do people ask about Selank and anxiety?
  2. What did the first comparison report?
  3. Does “similar” mean equivalent?
  4. What did the later comparisons examine?
  5. Does the add-on report prove that combining them is safe?
  6. What if I already take an anxiety medicine?
  7. What could help someone experiencing anxiety?
  8. Sources
LINKED BUILDING BLOCKSAmino acids joined into a chainSequence and structure both matter
Conceptual schematic. Simplified and not to scale; not a scan, microscopy image or validated simulation.

Why do people ask about Selank and anxiety?

Someone feeling stressed may want to feel calmer without losing concentration or feeling sleepy. Selank is a synthetic peptide discussed for those aims, and some small studies involved people with anxiety-related conditions. A temporary stressful situation and an anxiety disorder are not interchangeable, and a study in one group cannot automatically predict how another person will feel. Start with the Selank profile, or compare the questions behind Semax and Selank.14

What did the first comparison report?

A 2008 report described 62 people with generalised anxiety disorder or neurasthenia, an older diagnostic term involving symptoms including fatigue. Thirty received Selank and 32 received medazepam, an anxiety medicine. The authors described similar anxiety effects and reported additional effects on fatigue and alertness. The English abstract does not give the symptom-score differences, duration or enough information on study methods to establish how close the treatments really were. We reviewed that abstract, not the full Russian-language article.1

Does “similar” mean equivalent?

Not necessarily. If a small study does not show a clear difference, the treatments might be genuinely similar—or the study might be too imprecise to detect a meaningful difference. Establishing equivalence requires a suitable study design and a predefined range of differences that would count as acceptably small. An active-medicine comparison also answers a different question from a comparison with placebo. The 2008 abstract alone does not establish either equivalence or a reliable placebo-controlled effect.1

What did the later comparisons examine?

A 2014 report compared Selank with phenazepam, another anxiety medicine, in 60 people with anxiety-related or somatoform conditions. Its abstract describes an anxiety-reducing effect but does not give enough detail on allocation, blinding, placebo or numerical differences to establish equivalence. A separate 2015 report compared 30 people receiving phenazepam alone with 40 receiving phenazepam plus Selank. Its authors reported earlier improvement and fewer unwanted effects in the combined group. The abstract does not explain group assignment or blinding or provide numerical comparisons, so it cannot reliably establish the cause or size of those differences. We did not review the full Russian-language papers.23

Three reports, different comparisonsA guide to the abstracts, not a ranking of treatments.
  • 2008: 62 peopleSelank was compared with medazepam; the abstract described similar anxiety effects.
  • 2014: 60 peopleSelank was compared with phenazepam; the abstract did not give numerical group differences.
  • 2015: 70 peoplePhenazepam alone was compared with phenazepam plus Selank.
  • What is still needed?Clear methods, meaningful comparisons and adequate follow-up for benefits and harms.

Does the add-on report prove that combining them is safe?

No. The 2015 comparison is relevant, but it does not establish that adding an online Selank product to a prescribed medicine is effective or safe, or that it prevents withdrawal. A formulation used in a report may differ from another product, and interactions and long-term harms need specific study. FDA says important human safety information is missing for proposed compounded Selank acetate, including potential immune reactions and peptide impurities. See what a product certificate can and cannot establish.36

What if I already take an anxiety medicine?

Do not stop or change a prescribed medicine abruptly because of a peptide claim. Some medicines used for anxiety are benzodiazepines: the FDA notes that physical dependence can occur even with prescribed use, and stopping abruptly or reducing too quickly can cause serious withdrawal, including seizures. If you have questions about effectiveness, side effects or combining products, discuss them with your prescriber or pharmacist. This is a reason for an individual conversation, not a claim that everyone taking such a medicine has the same experience.54

What could help someone experiencing anxiety?

Anxiety becomes worth discussing with a qualified professional when it persists or interferes with daily life. Depending on the person’s needs, support may include talking therapy, medication or both; sleep, caffeine and other circumstances can also matter. A brain-scan pattern is another kind of observation, not a symptom score: see what the Semax and Selank imaging reports measured. For more starting points, visit stress and mood or focus and memory.4

Sources, kept close.

Selected supporting sources; this is not a complete literature review.

  1. Efficacy and possible mechanisms of action of a new peptide anxiolytic selank in the therapy of generalized anxiety disorders and neurastheniaZhurnal Nevrologii i Psikhiatrii / PubMed · Comparative human study; Russian-language article, English abstract; 2008Access checked 2026-11-05 · Only the English abstract and PubMed publication-type indexing were reviewed; blinding, duration and outcome scores were not described in the abstract.
  2. A comparison of the anxiolytic effect and tolerability of selank and phenazepam in the treatment of anxiety disordersZhurnal Nevrologii i Psikhiatrii / PubMed · Primary clinical report, Russian-language article with English abstract, 2014Accessed 2026-11-05
  3. Optimization of the treatment of anxiety disorders with selankZhurnal Nevrologii i Psikhiatrii / PubMed · Primary clinical report, English abstract reviewedAccess checked 2026-11-05 · Source date: 2015 · 30 phenazepam alone, 40 phenazepam plus Selank. Abstract reports earlier improvement and fewer side effects but does not detail allocation, blinding or numerical between-group differences; full Russian report not reviewed.
  4. Generalized Anxiety Disorder: What You Need to KnowU.S. National Institute of Mental Health · Public-health mental health guidanceAccess checked 2026-11-05 · General anxiety and care context; not a Selank study.
  5. FDA requiring Boxed Warning updated to improve safe use of benzodiazepine drug classU.S. Food and Drug Administration · Drug safety communicationAccess checked 2026-11-05 · Source date: 2020-09-23 · Class warning about dependence and withdrawal; does not evaluate Selank interactions.
  6. Certain bulk drug substances that may present significant safety risksU.S. Food and Drug Administration · Regulator safety recordAccessed 2026-11-05

The next useful question.

Substance profile

Selank.

A synthetic peptide discussed online for anxiety and cognition, with limited independently established clinical evidence and unresolved product-quality questions.

3 min read
Substance profile

Semax.

A synthetic peptide researched mainly in Russian-language contexts and sold online as a nootropic; its human evidence, product quality and regulatory status vary by jurisdiction.

4 min read